SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical
Biotech Valuation
An SI Board Since February 1999
Posts SubjectMarks Bans Symbol
52157 680 3 CRSP
Emcee:  Biomaven Type:  Moderated
Introduction Market Data Compact
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
ReplyMessage PreviewFromRecsPosted
51628Studies of antibody treatments, one of which was given to then President Trump. A.J. Mullen-1/26/2021
51627I saw this interesting article on blood stem cells. A close friend developed canOldAIMGuy-1/25/2021
51626My understanding from that tweet is the vaccine reduced infections of those who A.J. Mullen-1/24/2021
51625Reports from Israel are encouraging about infection prevention. twitter.comnigel bates-1/24/2021
51624Hard hitting note on the response to the Covid virus from Eric Topol and a coworA.J. Mullen21/24/2021
51623I was unable to get general access to JPM this year but accessed presentations tA.J. Mullen-1/23/2021
51622Well in the interest of sharing... I was randomly listening to JPM presentationsJamesK-1/23/2021
51621FGEN - Murine model of post MI Roxa preconditioning prior to reperfusion. Seemssemi_infinite 11/19/2021
51620Meant to refer to Dec 40p assignment.semi_infinite -1/19/2021
51619FGEN - sp is back to where the it was before the 90 day pdufa extension. I rolsemi_infinite -1/19/2021
51618Thanks Bulba, I have been following him there for some time. I still miss his cA.J. Mullen31/16/2021
51617You can follow Peter on Twitter at @Biomaven. Peace & good health, BulbaBulbaMan-1/16/2021
51616He was. His last post was almost a year ago. This thread is poorer without himA.J. Mullen-1/16/2021
51615Maybe. I took the explanation at face-value. The FTC did oppose the merger on A.J. Mullen-1/16/2021
51614Peter is an invaluable resource and moderator.IRWIN JAMES FRANKEL11/16/2021
51613<<<< Illumina, ILMN, was going to buy PACB, but was stopped because Steve Lokness-1/15/2021
51612Thank you for the compliment Lance. It'll make me more careful to read my pA.J. Mullen-1/15/2021
51611What I like about SI (and investor village) is that it allows for thoughtful expLance Bredvold-1/15/2021
51610The knowledgeable stalwarts of this thread have found new pastures. That's A.J. Mullen31/13/2021
516092021 Biotech Charity Contest: Post your next year's best biotech picks heretechnetium-12/26/2020
51608How the FDA regulates drug approval or disapproval would make for a full length Art Bechhoefer112/23/2020
51607RE - "another three or four years, when presumably the pamrevlumab drug wilsemi_infinite -12/23/2020
51606Hi JIm, Merry Christmas to you too, and all. When I said my net loss was pennA.J. Mullen-12/22/2020
51605When you should close out an options position may also have tax consequences in Art Bechhoefer-12/22/2020
51604The IV premium paid to option writers is a structural advantage. I would attribIRWIN JAMES FRANKEL-12/22/2020
Previous 25 | Next 25 | View Recent | Post Message
Go to reply# or date (mm/dd/yy):
HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2026 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News